In general, about one third of patients with a first renal stone develop a recurrence within 5 years. These patients are usually investigated for an underlying cause, such as primary hyperparathyroidism, renal tubular acidosis, urinary tract infection, and cystinuria. Urography, lately supplanted by noncontrast CT, is often included in the workup. Stone analysis often guides further studies.
A study based on data from the Swedish Inpatient Register and Swedish Cancer Registry followed over 61,000 patients hospitalized for renal or ureter stones and concluded that although these patients are not at risk for developing a future renal cell cancer, they are at increased risk for renal pelvis, ureter, and bladder cancer (110); chronic irritation and infection appear to play a role because tumors tended to develop on the same side as stones.
Associated Conditions
Epidemiologic studies have established an association between arterial hypertension and renal stone disease. Alterations in calcium metabolism play a role in both entities.
Over 5% of cystic fibrosis patients older than 15 years have had urolithiasis in the past.
Renal stone disease is induced by some drugs. In France, the most common drugs involved are calcium and vitamin D supplements and long-term therapy with carbonic anhydrase inhibitors (111). Furosemide therapy of premature neonates for hyaline membrane disease is associated with urolithiasis.
Occasionally reported is heterotopic ossification within a renal stone. A suture retained in the renal pelvis from prior surgery can act as a nidus for subsequent calcification.
Patients with primary hyperparathyroidism have an increased prevalence of renal stones,but only a small percentage of patients with idiopathic stones are hyperparathyroid.A metabolic defect is detected in about half of patients who develop calcium stones.
Calcium containing stones consist of calcium oxalate and calcium phosphate. Less common are magnesium ammonium phosphate (struvite) stones. Calcium oxalate stones are associated with certain blood groups. The prevalence of these stones in patients with blood group O is several times greater than in patients with blood group A.
ADVANCED IMAGING OF THE ABDOMEN
Patients with gout, Crohn’s disease involving the small bowel, and some myeloproliferative disorders have an increased prevalence of uric acid stones. Pure uric acid stones are lucent.
Cystine stones develop in a setting of cystinuria, a rare autosomal-recessive disorder. These stones form in the first and second decades of life, while uric acid stones form in older patients. Cystine stones are only slightly radiopaque and range from small to large. Recurrent stones are common, and lifetime surveillance is necessary in affected individuals.
Patients with struvite stones are prone to persistent infections.
Imaging
Imaging of suspected urinary obstruction is discussed in the previous Dilated Urinary Tract section.
Unenhanced CT readily identifies ureteral stones; keep in mind that with the use of wide collimation some smaller stones, especially uric acid stones, are insufficiently dense to be detected. Narrow collimation is thus necessary. At 1-mm collimation, stones can be grouped by attenuation: uric acid (least dense), cystine and struvite, calcium oxalate monohydrate, and brushite and hydroxyapatite (most dense) (112). In vitro CT using HU measurements of chemically pure stones identified the chemical composition of uric acid, struvite, and calcium oxalate stones, but could not differentiate calcium oxalate from brushite stones and struvite from cystine stones (113); the use of dual CT kilovoltage aids differentiation.
The sonographic appearance of a calculus reflects its size rather than its internal composition. Calculi are hyperechoic and, aside from small ones, have posterior acoustic shadowing (Fig. 10.31). Ultrasonography is insensitive in measuring stone size. Ultrasonography is better in detecting renal calculi than ureteral calculi. In women, transvaginal US can detect stones in the distal ureter, and this modality should be considered in the pregnant patient.
An interesting stone finding consists of a “twinkling”artifact detected by color and power Doppler US (114); this phenomenon appears as a rapidly changing color complex located behind a stone, similar to a comet’s tail. It aids in stone detection. Also, a twinkling artifact depends, in part, on stone composition. Thus it